Overview
The NHS Long Term Plan outlines that 4% of the total NHS carbon footprint savings are expected to be realised through a ‘shift to lower carbon inhalers’ equivalent to a 50% reduction in the inhaler carbon footprint. 1,2 The RDTC has developed an inhaler carbon impact assessment tool in response to these targets. It is intended to be used at a commissioning level to estimate the impact of respiratory pathway choices made following a clinical decision making process.
This is not a clinical switch tool and should only be used as a calculator to estimate the impact of respiratory pathway choices already made following a clinical decision making process.
User Verification
Please note that in order to access the tool users not only require an authorised RDTC website account but additional verification details. To request inclusion as a verified user please contact us at nuth.nyrdtc.rxsupp@nhs.net
References
2. Centre for Sustainable Healthcare (CSH) Networks. Inhalers and NHS Long Term Plan.
Data Period
July 2020 to June 2021
Frequency
Quarterly